Scilex Pharmaceuticals, Inc.

Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

Role: lead

Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

Role: lead

Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise

Role: lead

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects

Role: lead

Lidocaine Patch for Neck Pain

Role: collaborator

Corticosteroid Lumbar Epidural Analgesia for Radiculopathy

Role: lead

Pharmacokinetics of SP-104

Role: lead

Study to Evaluate the Safety of SP-104

Role: lead

A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

Role: collaborator

Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches

Role: lead

Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects

Role: lead

Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure

Role: lead

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects

Role: lead

Adhesion of Lidocaine Topical System 1.8%

Role: lead

Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

Role: lead